Medhealth insight

Drug Discovery and Development

Owkin signs deal with Merck to create and market AI-driven cancer diagnostics

Owkin, a biotech powerhouse blending French finesse with American innovation, has struck a collaboration chord with MSD, also known as Merck & Co. Inc. This duo aims to revolutionize...

Trending News

The red tape of regulation

Many companies understand and are committed...

Innovative walker with cues shows promising...

Maintaining an optimal level of physical...

How passive RFID technology can transform...

In today's fast-paced healthcare environments, hospitals...